On May 8, 2025, Tonix Pharmaceuticals held its annual shareholder meeting where seven proposals were approved, including a reverse stock split plan and an increase in the stock incentive plan by 1,000,000 shares. A total of 3,002,566 shares, which is 46.7% of outstanding shares, were represented in the voting.